NASDAQ:DRNA

Dicerna Pharmaceuticals Insider Trades

$36.90
-0.04 (-0.11 %)
(As of 08/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$35.89
$37.29
50-Day Range
$30.12
$39.99
52-Week Range
$16.50
$40.14
Volume499,470 shs
Average Volume762,803 shs
Market Capitalization$2.84 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.07

Dicerna Pharmaceuticals (NASDAQ:DRNA) Insider Buying and Selling Activity

10.20% of Dicerna Pharmaceuticals' shares are owned by company executives, directors and other insiders. Over the past twelve months, insiders at the biopharmaceutical company have sold shares 29 time(s), totalling $32,526,750.67. During the same time, Dicerna Pharmaceuticals insiders have purchased shares 1 time(s), totalling $180,600.00. Insiders that have sold shares include James B Weissman, Regina M Paglia, Robert D Ciappenelli, Bob D Brown, and Adam Koppel.

Insider Buying and Selling by Quarter


Dicerna Pharmaceuticals (NASDAQ DRNA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/6/2021James B WeissmanCOOSell30,000$39.09$1,172,700.00  
6/25/2021Regina M PagliaInsiderSell1,000$38.00$38,000.001,269  
6/22/2021Regina M PagliaInsiderSell18,435$36.99$681,910.6514,019  
6/16/2021Regina M PagliaInsiderSell31,564$35.63$1,124,625.32381  
6/14/2021Robert D CiappenelliInsiderSell20,000$38.00$760,000.0013,773  
6/11/2021Bob D BrownEVPSell10,000$34.00$340,000.0031,517  
6/7/2021Bob D BrownEVPSell10,000$33.00$330,000.0031,517  
6/1/2021Bob D BrownEVPSell8,312$30.93$257,090.1629,829  
6/1/2021Regina M PagliaInsiderSell4,431$30.94$137,095.144,431  
5/3/2021Bob D BrownEVPSell8,312$30.28$251,687.3629,829  
5/3/2021Regina M PagliaInsiderSell4,431$30.28$134,170.684,431  
4/29/2021Bob D BrownEVPSell10,000$31.00$310,000.0031,517  
4/16/2021James B WeissmanCOOSell4,904$29.99$147,070.9616,000  
4/1/2021Bob D BrownEVPSell8,312$25.87$215,031.4429,829  
4/1/2021Regina M PagliaInsiderSell4,431$25.86$114,585.664,431  
2/5/2021James B WeissmanCOOSell7,156$26.99$193,140.4420,904  
2/3/2021Bob D BrownEVPSell8,312$25.00$207,800.00
1/25/2021Bob D BrownEVPSell21,630$25.00$540,750.0043,147  
1/25/2021Regina M PagliaInsiderSell6,326$25.00$158,150.006,326  
1/12/2021Bob D BrownInsiderSell5,808$24.07$139,798.5626,517  
1/11/2021James B WeissmanCOOSell3,800$23.99$91,162.0040,510  
12/10/2020Adam KoppelDirectorSell1,000,000$23.40$23,400,000.00  
12/1/2020Bob D BrownInsiderSell8,185$25.19$206,180.1534,702  
12/1/2020James B WeissmanCOOSell4,360$25.21$109,915.6036,220  
11/4/2020Regina M PagliaInsiderSell30,000$22.75$682,500.0030,000  
11/2/2020Bob D BrownInsiderSell8,185$21.03$172,130.5534,702  
11/2/2020James B WeissmanCOOSell4,360$20.95$91,342.0036,220  
10/16/2020Bob D BrownInsiderSell16,370$21.00$343,770.0042,887  
10/15/2020James B WeissmanCOOSell8,720$20.20$176,144.0030,580  
9/1/2020Douglas FambroughCEOBuy10,000$18.06$180,600.0022,300  
8/3/2020Bob D BrownInsiderSell8,185$22.48$183,998.8013,185  
8/3/2020James B WeissmanCOOSell4,360$22.47$97,969.2025,961  
7/1/2020Bob D BrownInsiderSell8,185$26.50$216,902.5013,185  
7/1/2020James B WeissmanCOOSell4,360$26.53$115,670.8026,220  
6/19/2020Bob D BrownInsiderSell9,670$25.00$241,750.0014,670  
6/1/2020Bob D BrownInsiderSell8,185$21.01$171,966.8513,185  
6/1/2020James B WeissmanCOOSell4,360$21.06$91,821.6026,220  
5/11/2020Bob D BrownInsiderSell13,281$24.00$318,744.0018,281  
5/5/2020Bob D BrownInsiderSell8,185$21.00$171,885.0013,185  
5/4/2020James B WeissmanCOOSell4,360$20.20$88,072.0026,220  
4/20/2020Bob D BrownInsiderSell13,281$23.00$305,463.0013,185  
4/20/2020John B. GreenCFOSell25,624$22.95$588,070.80  
4/17/2020Bob D BrownInsiderSell8,185$21.18$173,358.3013,185  
4/13/2020James B WeissmanCOOSell4,360$20.20$88,072.0026,220  
4/7/2020John B. GreenCFOSell20,469$19.95$408,356.55  
3/2/2020Bob D BrownInsiderSell8,185$21.00$171,885.0013,185  
3/2/2020James B WeissmanCOOSell4,360$20.61$89,859.6026,220  
2/10/2020Bob D BrownInsiderSell8,185$21.00$171,885.0010,650  
2/3/2020James B WeissmanCOOSell4,360$20.20$88,072.0026,220  
1/17/2020John B. GreenCFOSell47,969$21.27$1,020,300.63  
1/2/2020James B WeissmanCOOSell4,360$21.88$95,396.8023,360  
12/31/2019Bob D BrownInsiderSell11,941$22.00$262,702.0017,855  
12/18/2019Douglas FambroughCEOSell80,000$25.87$2,069,600.00  
12/4/2019Adam KoppelDirectorSell1,500,000$24.68$37,020,000.00  
12/2/2019James B WeissmanCOOSell20,000$26.00$520,000.0034,704  
12/2/2019Peter KolchinskyDirectorSell137,176$24.98$3,426,656.48  
11/29/2019Peter KolchinskyDirectorSell138,000$24.22$3,342,360.00  
11/27/2019Peter KolchinskyDirectorSell368,700$24.04$8,863,548.00  
11/25/2019John B. GreenCFOSell12,500$24.95$311,875.00  
11/25/2019Peter KolchinskyDirectorSell361,200$24.06$8,690,472.00  
11/21/2019Peter KolchinskyDirectorSell351,505$22.98$8,077,584.90  
11/19/2019Bain Capital Life Sciences InvMajor ShareholderSell1,750,000$22.03$38,552,500.00  
11/19/2019James B WeissmanCOOSell20,000$24.00$480,000.0034,704  
11/19/2019Peter KolchinskyDirectorSell397,183$23.92$9,500,617.36  
11/18/2019John B. GreenCFOSell12,500$21.05$263,125.00  
11/14/2019James B WeissmanCOOSell20,000$20.00$400,000.0034,704  
11/14/2019John B. GreenCFOSell3,562$20.00$71,240.00  
10/31/2019James B WeissmanCOOSell15,000$18.00$270,000.0029,704  
10/31/2019John B. GreenCFOSell12,500$18.00$225,000.00  
8/23/2019James B WeissmanInsiderSell14,680$13.07$191,867.609,800  
5/29/2019Bain Capital Life Sciences InvDirectorSell1,600,000$12.50$20,000,000.00  
4/2/2019James B WeissmanInsiderSell15,000$15.00$225,000.0039,480  
11/6/2018Brian K HalakDirectorSell335,000$13.33$4,465,550.00  
11/1/2018Brian K HalakDirectorSell564,300$13.66$7,708,338.00  
10/30/2018Brian K HalakDirectorSell245,096$13.92$3,411,736.32  
9/5/2018James B WeissmanInsiderSell2,301$17.50$40,267.5026,781  
8/15/2018Dennis LangerDirectorSell14,531$16.00$232,496.0029,064  
5/9/2018James B WeissmanInsiderSell10,000$15.00$150,000.0019,800  
4/20/2018James B WeissmanInsiderSell8,965$13.00$116,545.009,800  
3/19/2018James B WeissmanInsiderSell1,035$13.00$13,455.0018,765  
12/18/2017Bain Capital Life Sciences InvDirectorBuy285,000$7.00$1,995,000.00  
11/16/2016Dennis LangerDirectorSell23,766$3.52$83,656.3243,595  
11/15/2016Douglas FambroughCEOBuy33,100$3.71$122,801.00  
5/12/2016James B WeissmanInsiderBuy5,000$3.29$16,450.0015,100  
11/25/2014James E FlynnInsiderSell321,965$11.36$3,657,522.40  
11/7/2014James E FlynnInsiderSell214,164$9.05$1,938,184.20  
10/15/2014James E FlynnInsiderSell117,778$10.86$1,279,069.08  
10/14/2014James E FlynnMajor ShareholderSell36,115$11.02$397,987.30  
10/10/2014James E FlynnMajor ShareholderSell30,214$12.13$366,495.82  
2/4/2014James E FlynnInsiderBuy1,000,000$15.00$15,000,000.00  
2/4/2014Stephen J HoffmanDirectorBuy200,000$15.00$3,000,000.00  
(Data available from 1/1/2013 forward)
This page was last updated on 8/4/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.